SHP2-IN-13 is an orally active, highly selective allosteric inhibitor targeting the SHP2 ''tunnel site, exhibiting an IC50 of 83.0 nM. It holds potential for research into cancers with RTK oncogenic drivers and diseases associated with SHP2.
Molekulargewicht:
327.38
CAS Nummer:
[2951854-02-5]
Formel:
C16H21N7O
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten